Glenmark Pharmaceuticals Limited — Updates, 25-11-2025: Press Release
25-11-2025 | 08:59 am
25-11-2025 | 08:59 am
Glenmark Pharma launched Nebzmart® GFB Smartules® and Glenmark Airz® FB Smartules®, the world's first nebulized triple therapy for COPD. This innovation offers improved lung function and symptom control, setting a new standard of care for patients, especially those unable to use traditional inhalers.
No comments yet. Be the first to comment!
